Evidence map›Paper›PMID 33552399›Full record

ArticleWorld journal of cardiology2021

Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus.

Temidayo Abe, Harry Onoriode Eyituoyo, Gabrielle De Allie, Titilope Olanipekun, Valery Sammah Effoe, Kikelomo Olaosebikan, Paul Mather

Open access · diamondAbstract read
In one paragraph

Article in World journal of cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Underrecognized pathogen;Clinical case reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Temidayo AbeDepartment of Internal Medicine, Morehouse School of Medicine, Atlanta, GA 30310, United States. tabe@msm.edu.
Harry Onoriode EyituoyoDepartment of Internal Medicine, Mercer University School of Medicine, Macon, GA 31207, United States.
Gabrielle De AllieDepartment of Internal Medicine, Morehouse School of Medicine, Atlanta, GA 30310, United States.
Titilope OlanipekunDepartment of Internal Medicine, Morehouse School of Medicine, Atlanta, GA 30310, United States.
Valery Sammah EffoeDepartment of Cardiovascular Disease, Morehouse School of Medicine, Atlanta, GA 30310, United States.
Kikelomo OlaosebikanDepartment of Medicine, University of Debrecen Medical and Health Science Center, Debrecen 4032, Hungary.
Paul MatherDepartment of Cardiovascular Disease, University of Pennsylvania, Pennsylvania, PA 19104, United States.
Mercer University · USUniversity of Pennsylvania · USUniversity of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a lack of data on the clinical outcomes in patients with native valve infective endocarditis (NVIE) and diabetes mellitus (DM).

aimTo investigate (1) trends in the prevalence of DM among patients with NVIE; and (2) the impact of DM on NVIE outcomes.

methodsWe identified 76385 with NVIE from the 2004 to 2014 National Inpatient Sample, of which 22284 (28%) had DM. We assessed trends in DM from 2004 to 2014 using the Cochrane Armitage test. We compared baseline comorbidities, microorganisms, and in-patients procedures between those with

resultsCrude rates of DM increased from in 22% in 2004 to 30% in 2014. There were significant differences in demographics, comorbidities and NVIE risk factors between the two groups. Staphylococcus aureus was the most common organism identified with higher rates in patients with DM (33.1%

conclusionThere is an increasing prevalence of DM in NVIE and it is associated with poorer outcomes. Further studies are crucial to identify the clinical, and sociodemographic contributors to this trend and develop strategies to mitigate its attendant risk.

Indexed as

Cardiovascular diseaseDiabetes mellitusInfective endocarditisNational Inpatient SampleNative valve infective endocarditisValvular heart disease

Identifiers

PMID33552399
PMCPMC7821010
OpenAlexW3124363289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.